Axios @axios
A federal appeals court dismissed two patent challenges from Moderna over key components involved in making its COVID-19 vaccine. The court's decision means Moderna could potentially face patent infringement lawsuits from Arbutus Biopharma. https://t.co/XR7WgBEZDj — PolitiTweet.org